Temporal deletion of IL‐4Rα chain after sensitization phase prevented disease development, whereas temporal deletion during the effector phase reduced most disease parameters, such as AHR, eosinophilia, as well as goblet cell metaplasia. This evidence concerns the gene AHR and Increased total eosinophil count.